Budget Impact Analysis—Principles of Good Practice: Report of the ISPOR 2012 Budget Impact Analysis Good Practice II Task Force-Reference-Cited by-同舟云学术

Budget Impact Analysis—Principles of Good Practice: Report of the ISPOR 2012 Budget Impact Analysis Good Practice II Task Force

Published:2014-01 Issue:1 Volume:17 Page:5-14
ISSN:1098-3015
Container-title:Value in Health
language:en
Short-container-title:Value in Health

Author:

Sullivan Sean D.,Mauskopf Josephine A.,Augustovski Federico,Jaime Caro J.,Lee Karen M.,Minchin Mark,Orlewska Ewa,Penna Pete,Rodriguez Barrios Jose-Manuel,Shau Wen-Yi

Publisher

Elsevier BV

Subject

Public Health, Environmental and Occupational Health,Health Policy

Reference28 articles.

1. Principles of good practice for budget impact analysis: report of the ISPOR Task Force on Good Research Practices—Budget Impact Analysis;Mauskopf;Value Health,2007

2. métodos y aplicaciones del análisis del impacto presupuestario en sanidad;Brosa;Pharmacoecon Spanish Res Artic,2005

3. Prevalence-based economic evaluation;Mauskopf;Value Health,1998

4. Developing guidance for budget impact analysis;Trueman;Pharmacoeconomics,2001

5. Proposal of Polish guidelines for conducting financial analysis and their comparison to existing guidance on budget impact in other countries;Orlewska;Value Health,2004

Cited by 781 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Assessing the Impact of a Designated Pharmacist Intervention on Drug Treatment Costs and Technical Efficiency in the Hemato-Oncology Outpatient Clinic;Value in Health Regional Issues;2024-11

2. Budget impact analysis of implementing trauma registries in Argentina;Injury;2024-11

3. Artificial-Intelligence Cloud-Based Platform to Support Shared Decision-Making in the Locoregional Treatment of Breast Cancer: Protocol for a Multidimensional Evaluation Embedded in the CINDERELLA Clinical Trial;PharmacoEconomics - Open;2024-09-12

4. Public Health and Economic Impact of Periodic COVID-19 Vaccination with BNT162b2 for Old Adults and High-Risk Patients in an Illustrative Prefecture of Japan: A Budget Impact Analysis;Infectious Diseases and Therapy;2024-09-10

5. Budget impact of dostarlimab plus carboplatin-paclitaxel for primary advanced or recurrent endometrial cancer from a third-party US payer perspective;Journal of Medical Economics;2024-09-10